eu convalescent plasma platform

11

EU Convalescent Plasma Platform Stéphane Bégué, European Blood AllianceOrsi Nagy, DG SANTE

2

The context A promising treatment

Starting the EU cooperation The Project team

DG SANTE B4 – policy

DG DIGIT D1 – technical aspects

European Blood alliance (NGO) – technical input on plasma / direct engagement with blood establishments

DG SANTE 02 and A1 - web and GDPR

DG CNECT – infrastructure (BDTI)

1. Strong existing cooperation of EU, ECDC, National Competent Authorities and Blood Establishments

2. Guidance document on the collection and transfusion of convalescent COVID-19 plasma to the donation, collection, testing, processing, storage, distribution and monitoring of convalescent plasma

3. Need for an European Open Database to collect practices and experience from European countries regarding CCP collection and use

3

Open-access database to gather data from monitored use of convalescent plasma, as well as from randomisedclinical trials

Aim: consolidate EU evidence on the safety and effectiveness of this promising therapy

Input: all EU/EEA blood establishments that wish to participate, via the EBA.

Go live: data collection module: April –continuous improvements. Last addition: dashboards

5

6

`

7

8

9

https://ec.europa.eu/health/blood_tissues_organs/covid-19_enhttps://www.euccp.dataplatform.tech.ec.europa.eu/

10

Click to edit Master title style

11

Click to edit Master title style